Clinical trial
HDE Post-Approval Study (PAS) of NeuRx DPS for ALS
NCT01605006 is registered in ClinicalTrials.gov with Synapse Biomedical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HDE Post-Approval Study (PAS) of NeuRx DPS for ALS
- Lead sponsor
- Synapse Biomedical
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- February 28, 2017
- Enrollment
- 97 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
amyotrophic lateral sclerosis (als)